Are Conditioned Open Placebos Feasible as an Adjunctive Treatment to Opioids? Results from a Single-Group Dose-Extender Pilot Study with Acute Pain Patients | Citedby Results | Psychotherapy and Psychosomatics | Karger Publishers

Skip to Main Content

Skip Nav Destination

Are Conditioned Open Placebos Feasible as an Adjunctive Treatment to Opioids? Results from a Single-Group Dose-Extender Pilot Study with Acute Pain Patients

Psychother Psychosom (2019) 88 (6): 380–382.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial

Matthijs de Leeuw
Mirjam Laager
Jens Gaab
Wilhelm Ruppen
Tobias Schneider

Frontiers in Medicine (2024) 11

Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder

Annabelle M. Belcher
Thomas O. Cole
Ebonie Massey
Amy S. Billing
Michael Wagner
William Wooten
David H. Epstein
Stephen W. Hoag
Emerson M. Wickwire
Aaron D. Greenblatt
Luana Colloca
John Rotrosen
Lawrence Magder
Eric Weintraub
Eric D. Wish
Ted J. Kaptchuk

JAMA Network Open (2023) 6 (4): e237099.

Experiences of Patients Taking Conditioned Open-Label Placebos for Reduction of Postoperative Pain and Opioid Exposure After Spine Surgery

Valerie Hruschak
K. Mikayla Flowers
Megan Patton
Victoria Merchantz
Emily Schwartz
Robert Edwards
Ted Kaptchuk
James Kang
Michelle Dossett
Kristin Schreiber

International Journal of Behavioral Medicine (2023) 30 (4): 509.

Irving Kirsch opens a window on antidepressant medications

Emma Grace Chen
Alison Kate Oliver
Amir Raz

American Journal of Clinical Hypnosis (2023) 65 (3): 223.

“Let’s see what happens:”—Women’s experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial

Yiqi Pan
Miriam L. Frank
Ted J. Kaptchuk
Yvonne Nestoriuc
Walid Kamal Abdelbasset

PLOS ONE (2022) 17 (11): e0276499.

Escalating morphine dosage fails to elicit conditioned analgesia in a preclinical chronic neuropathic pain model

Damien C. Boorman
Kevin A. Keay

Behavioural Pharmacology (2021) 32 (6): 479.

Lay perspectives of the open-label placebo rationale: a qualitative study of participants in an experimental trial

Cosima Locher
Sarah Buergler
Antje Frey Nascimento
Linda Kost
Charlotte Blease
Jens Gaab

BMJ Open (2021) 11 (8): e053346.

Treating Pain With Open-Label Placebos: A Qualitative Study With Post-Surgical Pain Patients

Michael H. Bernstein
Nathaniel Fuchs
Maayan Rosenfield
Arnold-Peter Weiss
Charlotte Blease
Cosima Locher
Molly Magill
Josiah Rich
Francesca L. Beaudoin

The Journal of Pain (2021) 22 (11): 1518.

How orthopedic surgeons view open label placebo pills: Ethical and effective, but opposed to personal use

Michael H. Bernstein
Maayan Rosenfield
Nathaniel Fuchs
Molly Magill
Charlotte R. Blease
Francesca L. Beaudoin
Josiah D. Rich
Karolina Wartolowska
Richard M. Terek

Journal of Psychosomatic Research (2021) 151: 110638.

Conditioning open-label placebo: a pilot pharmacobehavioral approach for opioid dose reduction and pain control

Leon Morales-Quezada
Ines Mesia-Toledo
Anayali Estudillo-Guerra
Kevin C. O'Connor
Jeffrey C. Schneider
Douglas J. Sohn
David M. Crandell
Ted Kaptchuk
Ross Zafonte

PAIN Reports (2020) 5 (4): e828.